NORDIC PHARMA, INC.
BERWYN, PA

NORDIC PHARMA, INC., formerly known as Amring Pharmaceuticals Inc., is a privately-held pharmaceutical company located in Berwyn, Pennsylvania. Incorporated on July 14, 2015, the company primarily focuses on Oncology, Women’s Health, Anesthesiology & Pain Therapy, Respiratory, Rheumatology, Gastroenterology, and Post-natal Diabetes treatment areas. Known for its agile business structure and commitment to success, NORDIC PHARMA is dedicated to improving lives through innovative pharmaceuticals with a lean central organization that facilitates quick decision-making processes. The company operates globally in partnership with esteemed biopharmaceutical companies, capitalizing on advanced biotechnology-derived medicines, patient-friendly drug delivery systems, sterile manufacturing, and other leading-edge technologies. NORDIC PHARMA's leadership comprises President Philip Gioia, CFO Tatyana Kosheleva, and Director Sean Davis. Headquartered at 1205 Westlakes Dr., Berwyn, PA, the company is registered in Florida under File Number F15000003071 with a FEI number of 47-1604786. The website for NORDIC PHARMA is [amringpharmaceuticals.com](http://www.amringpharmaceuticals.com). Its most recent significant corporate event was a name change and amendment on March 1, 2024, with the last annual report filed on January 4, 2024.